Search Clinical Trials ?


Trials Open: 2
Cancer Type: Breast - Female
Protocol No.Title
NCI-CIRB-LAO-OH007-9876NCI-CIRB-LAO-OH007-9876: Phase 1b Study of HSP90 Inhibitor, AT13387 in Combination with Paclitaxel in Patients with Advanced, Triple Negative Breast Cancer
NSABP-B-57-I/AFT-05NSABP-B-57-I/AFT-05: PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer